United Therapeutics Corporation
TREATMENT FOR INTERSTITIAL LUNG DISEASE

Last updated:

Abstract:

Methods of treating of interstitial lung disease, reducing pulmonary function decline in a subject with interstitial lung disease (ILD), and increasing forced vital capacity (FVC) in a subject suffering from ILD are provided, wherein the methods include administration of treprostinil.

Status:
Application
Type:

Utility

Filling date:

16 Apr 2021

Issue date:

28 Oct 2021